Cargando…

New insights into the phenotype of FARS2 deficiency

Mutations in FARS2 are known to cause dysfunction of mitochondrial translation due to deficient aminoacylation of the mitochondrial phenylalanine tRNA. Here, we report three novel mutations in FARS2 found in two patients in a compound heterozygous state. The missense mutation c.1082C > T (p.Pro36...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vantroys, Elise, Larson, Austin, Friederich, Marisa, Knight, Kaz, Swanson, Michael A., Powell, Christopher A., Smet, Joél, Vergult, Sarah, De Paepe, Boel, Seneca, Sara, Roeyers, Herbert, Menten, Björn, Minczuk, Michal, Vanlander, Arnaud, Van Hove, Johan, Van Coster, Rudy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academic Press 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5734183/ https://www.ncbi.nlm.nih.gov/pubmed/29126765 http://dx.doi.org/10.1016/j.ymgme.2017.10.004

Ejemplares similares

Severe hepatopathy and neurological deterioration after start of valproate treatment in a 6-year-old child with mitochondrial tryptophanyl-tRNA synthetase deficiency
por: Vantroys, Elise, et al.
Publicado: (2018)

Urine lactate concentration as a non-invasive screener for metabolic abnormalities: Findings in children with autism spectrum disorder and regression
por: Boterberg, Sofie, et al.
Publicado: (2022)

Leigh syndrome followed by parkinsonism in an adult with homozygous c.626C>T mutation in MTFMT
por: Hemelsoet, Dimitri M., et al.
Publicado: (2018)

A Bumpy Ride on the Diagnostic Bench of Massive Parallel Sequencing, the Case of the Mitochondrial Genome
por: Vancampenhout, Kim, et al.
Publicado: (2014)

A Critical Assessment of the Therapeutic Potential of Resveratrol Supplements for Treating Mitochondrial Disorders
por: De Paepe, Boel, et al.
Publicado: (2017)

Clinical Heterogeneity in MT-ATP6 Pathogenic Variants: Same Genotype—Different Onset
por: Capiau, Sara, et al.
Publicado: (2022)

Clinical variability in neurohepatic syndrome due to combined mitochondrial DNA depletion and Gaucher disease
por: Harvengt, Julie, et al.
Publicado: (2014)

Mitochondrial mosaics in the liver of 3 infants with mtDNA defects
por: Roels, Frank, et al.
Publicado: (2009)

Clinical and genetic aspects of defects in the mitochondrial iron–sulfur cluster synthesis pathway
por: Vanlander, A. V., et al.
Publicado: (2018)

Correction to: Clinical and genetic aspects of defects in the mitochondrial iron–sulfur cluster synthesis pathway
por: Vanlander, A. V., et al.
Publicado: (2018)

Mild myopathic phenotype in a patient with homozygous c.416C > T mutation in TK2 gene
por: Papadimas, George K., et al.
Publicado: (2020)

Nanoscopic X-ray fluorescence imaging and quantification of intracellular key-elements in cryofrozen Friedreich’s ataxia fibroblasts
por: De Samber, Björn, et al.
Publicado: (2018)

Lactic Acidosis in a Newborn With Adrenal Calcifications
por: Zecic, Alexandra, et al.
Publicado: (2009)

Biallelic Mutations in TMEM126B Cause Severe Complex I Deficiency with a Variable Clinical Phenotype
por: Alston, Charlotte L., et al.
Publicado: (2016)

Implementation of non‐invasive prenatal testing by semiconductor sequencing in a genetic laboratory
por: Dheedene, Annelies, et al.
Publicado: (2016)

Familial cases of a submicroscopic Xp22.2 deletion: genotype-phenotype correlation in microphthalmia with linear skin defects syndrome
por: Vergult, Sarah, et al.
Publicado: (2013)

Identification of Two Critically Deleted Regions within Chromosome Segment 7q35-q36 in EVI1 Deregulated Myeloid Leukemia Cell Lines
por: De Weer, An, et al.
Publicado: (2010)

Publisher Correction: BATCH-GE: Batch analysis of Next-Generation Sequencing data for genome editing assessment
por: Boel, Annekatrien, et al.
Publicado: (2018)

BATCH-GE: Batch analysis of Next-Generation Sequencing data for genome editing assessment
por: Boel, Annekatrien, et al.
Publicado: (2016)

Sporadic Inclusion Body Myositis: An Acquired Mitochondrial Disease with Extras
por: De Paepe, Boel
Publicado: (2019)

Progressive Skeletal Muscle Atrophy in Muscular Dystrophies: A Role for Toll-Like Receptor-Signaling in Disease Pathogenesis
por: De Paepe, Boel
Publicado: (2020)

The Cytokine Growth Differentiation Factor-15 and Skeletal Muscle Health: Portrait of an Emerging Widely Applicable Disease Biomarker
por: De Paepe, Boel
Publicado: (2022)

Incorporating circulating cytokines into the idiopathic inflammatory myopathy subclassification toolkit
por: De Paepe, Boel
Publicado: (2023)

What Nutraceuticals Can Do for Duchenne Muscular Dystrophy: Lessons Learned from Amino Acid Supplementation in Mouse Models
por: De Paepe, Boel
Publicado: (2023)

Severe neonatal onset neuroregression with paroxysmal dystonia and apnoea: Expanding the phenotypic and genotypic spectrum of CARS2‐related mitochondrial disease
por: Poquérusse, Jessie, et al.
Publicado: (2023)

No evidence for involvement of SDHD in neuroblastoma pathogenesis
por: De Preter, Katleen, et al.
Publicado: (2004)

Expanding the Phenotype of B3GALNT2-Related Disorders
por: D’haenens, Erika, et al.
Publicado: (2022)

Clinical, biochemical, and genetic spectrum of seven patients with NFU1 deficiency
por: Ahting, Uwe, et al.
Publicado: (2015)

Far Ultraviolet Detector Standards
por: Canfield, L. Randall, et al.
Publicado: (1987)

Scanning for Therapeutic Targets within the Cytokine Network of Idiopathic Inflammatory Myopathies
por: De Paepe, Boel, et al.
Publicado: (2015)

The Role of Taurine in Skeletal Muscle Functioning and Its Potential as a Supportive Treatment for Duchenne Muscular Dystrophy
por: Merckx, Caroline, et al.
Publicado: (2022)

Identification of long non-coding RNAs involved in neuronal development and intellectual disability
por: D’haene, Eva, et al.
Publicado: (2016)

Dealing with an Unconventional Genetic Code in Mitochondria: The Biogenesis and Pathogenic Defects of the 5-Formylcytosine Modification in Mitochondrial tRNA(Met)
por: Van Haute, Lindsey, et al.
Publicado: (2017)

Cytokines and Chemokines as Regulators of Skeletal Muscle Inflammation: Presenting the Case of Duchenne Muscular Dystrophy
por: De Paepe, Boel, et al.
Publicado: (2013)

The PKA-p38MAPK-NFAT5-Organic Osmolytes Pathway in Duchenne Muscular Dystrophy: From Essential Player in Osmotic Homeostasis, Inflammation and Skeletal Muscle Regeneration to Therapeutic Target
por: Herbelet, Sandrine, et al.
Publicado: (2021)

Correction to: The long non-coding RNA SAMMSON is essential for uveal melanoma cell survival
por: Dewaele, Shanna, et al.
Publicado: (2021)

The long non-coding RNA SAMMSON is essential for uveal melanoma cell survival
por: Dewaele, Shanna, et al.
Publicado: (2021)

WisecondorX: improved copy number detection for routine shallow whole-genome sequencing
por: Raman, Lennart, et al.
Publicado: (2019)

CRISPR/Cas9-mediated genome editing in naïve human embryonic stem cells
por: Jacobs, Eva Z., et al.
Publicado: (2017)

Abnormal NFAT5 Physiology in Duchenne Muscular Dystrophy Fibroblasts as a Putative Explanation for the Permanent Fibrosis Formation in Duchenne Muscular Dystrophy
por: Herbelet, Sandrine, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_o9tgq71aggh7qncb8ubm1gg4mq